Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,577 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06026163RecruitingPhase 2/Phase 3
Caffeine for breathing help in late preterm babies
This trial tests if giving caffeine to late preterm babies with breathing problems helps them need less breathing support. It could be an extra treatment alongside standard care.
Madinah, Medina RegionAges 1 day–3 days - NCT05339984Recruiting
MRI-based planning during liver surgery and related procedures
This study uses MRI imaging and computer modeling to better plan liver surgery and related liver treatments. It may help doctors predict circulation (blood flow) changes during surgery and choose safer surgical timing or approaches.
Villejuif, Val de MarneAges 18 years+ - NCT05649514Recruiting
Studying sleep problems in early Alzheimer’s risk patients
This study looks at sleep problems in people with mild Alzheimer’s disease and whether sleep measurements and questionnaires can help researchers understand early changes. You may be able to join if your diagnosis is mild and you can complete repeated sleep and thinking questionnaires with a family caregiver’s help.
Montpellier, HéraultAges 50–85 - NCT06416722Recruiting
Remote therapy with two tasks at once for Parkinson's
This study tests whether a remote therapy program that combines physical exercises with a thinking task can help people with Parkinson's walk better and think more clearly. It's done from home using a smartphone or computer.
Istanbul, BakırköyAges 30–75 - NCT06892795Enrolling by invitation
Predicting low body temperature during surgery in children
This study aims to predict which children might get too cold during surgery under general anesthesia lasting more than 30 minutes. It's trying to create a simple checklist to help doctors keep kids warm and safe.
Harbin, HeilongjiangAges Up to 15 years - NCT06891911Recruiting
Free healthy groceries to help lower blood pressure
This study gives people with high blood pressure free healthy groceries for 4 weeks to see if eating better can lower their blood pressure. It might help you get your blood pressure into a healthier range.
Boston, MassachusettsAges 18 years+ - NCT06891352Recruiting
Timing meals to reduce disease risk in night shift workers
This study tests whether adjusting when you eat (time-restricted eating) can improve health in night shift workers. You would use a smartphone app to track your meals and follow a set eating schedule for up to a year.
La Jolla, CaliforniaAges 18–70 - NCT06898476Recruiting
Silkworm pupa powder for Alzheimer's disease
This study tests if a powder made from silkworm pupae can help improve memory and thinking in people with Alzheimer's disease. It is for people with mild to severe Alzheimer's who have clear signs of the disease in their blood or brain scans.
Hangzhou, ZhejiangAges 50–90 - NCT06896903Recruiting
Testing heart artery function with and without nitroglycerin
This study compares two ways of testing the small blood vessels in the heart to understand chest pain when no major blockages are found. It may help doctors learn more about why you have chest pain and how to treat it.
Plano, TexasAges 18 years+ - NCT06893965Recruiting
Eye pressure check after Eylea 8mg injection
This trial measures eye pressure right after an injection of a higher-dose Eylea (aflibercept 8mg) to see how it affects the eye. It may help people who need frequent anti-VEGF shots for conditions like wet AMD or diabetic eye disease.
Toulon, VarAges 18 years+ - NCT06899997Recruiting
Alimentation limitée dans le temps pour les femmes obèses
Cette étude teste si limiter les heures de repas (par exemple, manger seulement entre 8h et 18h) améliore le système immunitaire des femmes obèses. Vous pourriez y participer si vous avez un IMC entre 40 et 50 ou un poids normal.
ParisAges 18–64 - NCT06898853Recruiting
Eye drops for dry eye: A 12-week study
This trial tests whether an anti-inflammatory eye drop (ciclosporin A) can help dry eyes by changing immune cells on the eye's surface. It lasts 12 weeks and may be an option for people with moderate to severe dry eye.
Sydney, New South WalesAges 18 years+ - NCT06895018Enrolling by invitation
Grape Drink Trial for Diabetes and Fatty Liver
This study tests a drink made from grape pomace (a natural byproduct) that is rich in polyphenols—compounds that may help the liver and heart. Participants have type 2 diabetes and mild fatty liver, and researchers want to see if the drink improves liver health, blood sugar, and gut bacteria over several months.
NaplesAges 35–70 - NCT06897488RecruitingPhase 2
Omitting endocrine therapy and radiation in low-risk breast cancer
This trial tests whether older women with very low-risk, hormone-positive breast cancer can safely skip endocrine therapy (hormone-blocking pills) and radiation after lumpectomy. It aims to maintain quality of life while keeping cancer from coming back.
Houston, TexasAges 60 years+ - NCT06891456Recruiting
Pulsed field ablation for ventricular tachycardia after heart attack
This trial tests a new type of energy (pulsed field ablation) to treat a fast heart rhythm called ventricular tachycardia that happens after a heart attack. The goal is to stop the dangerous rhythm without damaging nearby healthy tissue.
Cleveland, OhioAges 18 years+ - NCT06896773Enrolling by invitation
Training in low oxygen conditions and heart health
This study tests whether training in a room with less oxygen (like being at high altitude) changes heart health markers in male cyclists. It may help understand if this type of training is safe and effective.
Warsaw, Masovian VoivodeshipAges 20–40 - NCT06891573Recruiting
Lifestyle trial to prevent frailty and aging-related diseases
This study tests whether a lifestyle intervention can help prevent frailty and age-related health problems. If you are between 60 and 90 years old, have some signs of frailty, and can use a mobile app with help, you may be able to join.
IncheonAges 60–90 - NCT06898827Enrolling by invitation
Virtual reality distraction therapy for cardiac rehab
This trial tests whether using virtual reality (VR) during cardiac rehabilitation can help distract you from discomfort or anxiety. If you have a heart condition or have had a heart event and are starting rehab, you may be able to join.
MsidaAges 40 years+ - NCT06900244Enrolling by invitation
Metabolic Imaging for MS and Stroke
This study uses a special type of MRI scan to look at how energy is used in the brain. It may help researchers better understand neurological diseases like multiple sclerosis (MS) and stroke.
OxfordAges Up to 99 years - NCT06888973Enrolling by invitationPhase 1/Phase 2
Stem cell infusion for autoimmune diseases
This clinical trial is testing if infusions of special stem cells (called mesenchymal stem cells) can help people with certain autoimmune diseases where standard treatments have not worked well enough. It is an early-phase study in Pakistan for adults (and some children for one condition) with rheumatoid arthritis, lupus, systemic sclerosis, ankylosing spondylitis, or dermatomyositis/polymyositis.
RawalpindiAges 18–50 - NCT06888960RecruitingEarly Phase 1
Testing CC312 for people with autoimmune diseases
This early-phase study tests a new drug called CC312 in patients with certain autoimmune diseases like lupus, myositis, scleroderma, rheumatoid arthritis, immune thrombocytopenia, or autoimmune hemolytic anemia. The goal is to see if it's safe and how the body handles it.
Tianjin, ChinaAges 18 years+ - NCT06883305RecruitingPhase 3
Testing tezepelumab for moderate to severe COPD
This trial tests tezepelumab, an injected medication, for people with moderate to very severe COPD who still have flare-ups despite using standard inhalers. It may help reduce flare-ups and improve breathing for those with higher eosinophil levels.
Foley, AlabamaAges 40–80 - NCT06880393RecruitingPhase 2
BCMA CAR-T for high-risk multiple myeloma
This trial tests a new immunotherapy called BCMA CAR-T for people with multiple myeloma that is considered high-risk. It aims to see if this treatment can help patients who had a short response to initial therapy or have specific genetic changes in their cancer.
TianjinAges 18–75 - NCT06880263Enrolling by invitation
VR training to help nurses manage delirium
This trial tests if virtual reality (VR) training can improve how nurses care for patients with delirium (sudden confusion). It is for nurses who work directly with patients in a hospital setting.
TaipeiAges 20–65
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,577 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.